[Recommendations for improving the predictive value of phase I to III data concerning the clinical and biological tolerance of a new drug].
M
M
Auriche
D002986:Clinical Trials as Topic / Q000379:methods; D004341:Drug Evaluation; D004361:Drug Tolerance; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D013223:Statistics as Topic / Q000592:standards
Recommandations pour améliorer la valeur prédictive des données des phases I à III concernant la tolérance clinique et biologique d'un nouveau médicament.